Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NOVALGIN: 19 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
19
Total FAERS Reports
2 (10.5%)
Deaths Reported
9
Hospitalizations
19
As Primary/Secondary Suspect
1
Life-Threatening

First Report: 2008 · Latest Report: 20140509

What Are the Most Common NOVALGIN Side Effects?

#1 Most Reported
Pulmonary artery stenosis congenital
6 reports (31.6%)
#2 Most Reported
Neonatal respiratory distress syndrome
6 reports (31.6%)
#3 Most Reported
Macrocephaly
6 reports (31.6%)

All NOVALGIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Atrial septal defect 6 31.6% 0 1
Macrocephaly 6 31.6% 0 1
Neonatal respiratory distress syndrome 6 31.6% 0 1
Pulmonary artery stenosis congenital 6 31.6% 0 1
Agranulocytosis 5 26.3% 2 3

Who Reports NOVALGIN Side Effects? Age & Gender Data

Average age: 39.1 years. Most reports from: DE. View detailed demographics →

Is NOVALGIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2008 5 0 1
2013 5 0 5
2014 6 1 3

View full timeline →

What Is NOVALGIN Used For?

IndicationReports
Product used for unknown indication 5

Official FDA Label for NOVALGIN

Official prescribing information from the FDA-approved drug label.